CliffBio
small molecule

TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER

AMINO ACIDS; DEXTROSE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
Active ingredientAMINO ACIDS; DEXTROSE
Strength4.25%;10GM/100ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalSeptember 1988
Marketing statusDISCN

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.